5th Drug Formulation & Bioavailability – 5th Drug Formulation & Bioavailability
Most of the drugs and APIs currently on the market are poorly water-soluble and need to have their bioavailability improved through the development of enabled formulations and patient-centric delivery mechanisms. Despite the promises of many “next generation” techniques, the biopharma industry continues to rely on refinements to amorphous solid dispersions and hot melt extrusions. Formulation professionals will continue to face challenges in the solubility and characterization of these drug delivery methods for years to come.
Now in its fifth year, the Drug Formulation, Solubility and Bioavailability conference is geared toward improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods.
Top Five Reasons to Attend
More than 30 speakers and eight hours of networking in a three-day program, featuring experts from AbbVie, Amgen, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Ferring, Genentech, GlaxoSmithKline, Johnson & Johnson, Lundbeck, Merck, Novartis, and many other organizations
Optimal techniques to increase dose loading in early stages when little drug material is available
Special emphasis on how to select the ideal excipients for both small molecules and biologics
A road map for improving drug characterization techniques without getting swamped by an overabundance of data
In-depth insights on the latest advances in subcutaneous, inhalation, oral and ocular drug delivery methods
By popular demand, this conference also features the 2016 Solubility Seminar, a full-day intensive devoted to the solubility challenges faced by formulation professionals at every stage of their careers, with a special emphasis on working with amorphous solids. These challenges never go away, so make sure your skills are always up to date!
Who Should Attend
Pharma, biotech and drug delivery scientific professionals responsible for: